D. E. Shaw & Co., Inc. Insmed Inc Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Insmed Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 288,551 shares of INSM stock, worth $21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

288,551

Previous 174,022 65.81%

Holding current value

$21 Million

Previous $4.72 Million 309.49%

% of portfolio

0.02%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $2.52 Million - $7.98 Million	114,529 Added 65.81%	288,551 $19.3 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $12.2 Million - $14.2 Million	-472,885 Reduced 73.1%	174,022 $4.72 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $10.5 Million - $14.3 Million	450,180 Added 228.83%	646,907 $20 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $1.94 Million - $2.63 Million	97,823 Added 98.91%	196,727 $4.97 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $2.28 Million - $2.92 Million	-138,463 Reduced 58.33%	98,904 $2.09 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $3.09 Million - $4.13 Million	-189,916 Reduced 44.45%	237,367 $4.05 Million
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $3.56 Million - $4.85 Million	-209,710 Reduced 32.92%	427,283 $8.54 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $5.48 Million - $7.4 Million	262,347 Added 70.03%	636,993 $13.7 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $1.34 Million - $2.02 Million	78,653 Added 26.57%	374,646 $7.39 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $157,989 - $217,641	-7,737 Reduced 2.55%	295,993 $6.96 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $1.56 Million - $2.02 Million	-60,254 Reduced 16.55%	303,730 $8.27 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $1.33 Million - $1.74 Million	-59,162 Reduced 13.98%	363,984 $10 Million
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $7.9 Million - $11.8 Million	-326,663 Reduced 43.57%	423,146 $12 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $8.16 Million - $11.2 Million	-252,688 Reduced 25.21%	749,809 $25.5 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $19.3 Million - $24.8 Million	-612,553 Reduced 37.93%	1,002,497 $33.4 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $3.45 Million - $4.58 Million	-132,657 Reduced 7.59%	1,615,050 $51.9 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $6.9 Million - $14.4 Million	-489,141 Reduced 21.87%	1,747,707 $48.1 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $10.3 Million - $25.6 Million	-754,627 Reduced 25.23%	2,236,848 $35.9 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $6.93 Million - $10.7 Million	430,169 Added 16.79%	2,991,475 $71.4 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $5.3 Million - $8.83 Million	342,359 Added 15.43%	2,561,306 $45.2 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $37.4 Million - $52.3 Million	1,625,381 Added 273.83%	2,218,947 $56.8 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $7.19 Million - $16.1 Million	516,860 Added 673.82%	593,566 $17.3 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $828,344 - $1.34 Million	-71,409 Reduced 48.21%	76,706 $1.01 Million
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $4.19 Million - $6.21 Million	-221,210 Reduced 59.9%	148,115 $3 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $1.51 Million - $2.24 Million	75,347 Added 25.63%	369,325 $8.74 Million
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $4.63 Million - $7.04 Million	-213,347 Reduced 42.05%	293,978 $6.62 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $8.09 Million - $9.73 Million	-306,237 Reduced 37.64%	507,325 $15.8 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $9.45 Million - $25.4 Million	813,562	813,562 $25.4 Million

Others Institutions Holding INSM

# of Institutions

447

Shares Held

170M

Call Options Held

5.79M

Put Options Held

5.18M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.88B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account